Article

wsj.com on 2021-05-11 02:00

Novavax delays its COVID-19 vaccine timeline

Novavax Inc. has delayed plans to seek regulatory clearances for its COVID-19 vaccine, while shortages in raw materials are slowing the ramp-up of ...

Related news

Novavax advances its Covid-19 vaccine trials. Here's the latest.bizjournals.com
Novavax says its COVID-19 vaccine is 90 percent effective The Verge
United Kingdom , Mexico
Novavax asks FDA to authorize its COVID-19 vaccine israelnationalnews.com
Mexico , United States
Novavax delays FDA submissions on its Covid vaccine as it says U.S. is pausing funding for production bizjournals.com
Novavax reports positive phase 1 data on its Covid-19 vaccine candidate bizjournals.com
Novavax receives first emergency use authorization for its Covid-19 vaccine bizjournals.com
BNovavax Stock Is Soaring. Analysts Say Its Covid-19 Vaccine Might Be the Best.barrons.com
Phase 1 , Stock Island
BNovavax Reported Promising Data on Covid-19 Vaccine. Its Stock Fell Anyway.barrons.com
Phase 1
Novavax vaccine seems effective against COVID-19, its new strains, in study ocregister.com
Novavax positions its COVID-19 vaccine as "universal booster of choice"newatlas.com
United Kingdom , United States , Philippines , Indonesia , India
Novavax expresses fresh confidence in its vaccine POLITICO
South Korea , Maryland , New Zealand , Australia , Canada
Novavax Covid-19 vaccine wins FDA authorization POLITICO
Mexico , United States , Chile
How the Novavax Covid-19 vaccine works CNN
South Africa , United Kingdom , Mexico , Texas , North Carolina
Covid-19: Switzerland approves Novavax vaccine thelocal.ch
Switzerland
Japan approves Novavax COVID-19 vaccine Seattle Times
Maryland , Japan
PNovavax Covid-19 vaccine shows 85.6% efficacy pendect.com
South Africa , United Kingdom